| 1 | approximately | 12,394 |
| 2 | roughly | 398 |
| 3 | biasp | 82 |
| 4 | tween | 75 |
| 5 | padma | 53 |
| 6 | polysorbate | 29 |
| 7 | clnp | 23 |
| 8 | itca | 19 |
| 9 | circa | 15 |
| 10 | superdex | 15 |
| 11 | antho | 8 |
| 12 | microgynon | 8 |
| 13 | approximatively | 7 |
| 14 | epub | 7 |
| 15 | gi-containing | 6 |
| 16 | regprecise | 6 |
| 17 | corpitolinol | 5 |
| 18 | enalapril/nitrendipine | 5 |
| 19 | microgynon® | 5 |
| 20 | anti-polio | 4 |
| 21 | ispm | 4 |
| 22 | mg/dimenhydrinate | 4 |
| 23 | veramex | 4 |
| 24 | 'affects | 3 |
| 25 | 3-keto-1,5-bisphosphonates | 3 |
| 26 | adi-peg | 3 |
| 27 | approximatly | 3 |
| 28 | as101 | 3 |
| 29 | atleast | 3 |
| 30 | coumarin-tween | 3 |
| 31 | guna-interleukin | 3 |
| 32 | lexis | 3 |
| 33 | osteoform | 3 |
| 34 | pegasus-timi | 3 |
| 35 | poloxalene | 3 |
| 36 | trombopol | 3 |
| 37 | 2-pyrimidinylnitrenes | 2 |
| 38 | 4-amino-3-methyl-5-styrylisoxazole | 2 |
| 39 | anthropac | 2 |
| 40 | cand | 2 |
| 41 | crambescidin | 2 |
| 42 | fagaridine | 2 |
| 43 | l-nitromonomethylarginine | 2 |
| 44 | monosomies | 2 |
| 45 | novomix | 2 |
| 46 | plaza | 2 |
| 47 | registred | 2 |
| 48 | roux-en- | 2 |
| 49 | tepc | 2 |
| 50 | va/scd | 2 |
| 51 | 'mikurasima | 1 |
| 52 | 'revman | 1 |
| 53 | -1093+59 | 1 |
| 54 | -across | 1 |
| 55 | /design | 1 |
| 56 | 0.1+/- | 1 |
| 57 | 0.34-10.8 | 1 |
| 58 | 0.5nmol/kbw | 1 |
| 59 | 0·93-3·87 | 1 |
| 60 | 11-to | 1 |
| 61 | 11.6± | 1 |
| 62 | 13.2± | 1 |
| 63 | 135·07± | 1 |
| 64 | 162/217 | 1 |
| 65 | 17.7± | 1 |
| 66 | 1986-april | 1 |
| 67 | 1h-session | 1 |
| 68 | 2,3,4,5-tetrahydro-1h-carbazole-6,11-diones | 1 |
| 69 | 2,39 | 1 |
| 70 | 2-aryl-2,3-dihydrobenzofuran | 1 |
| 71 | 20.888 | 1 |
| 72 | 2001-november | 1 |
| 73 | 2003-november | 1 |
| 74 | 2005-september | 1 |
| 75 | 2006-august | 1 |
| 76 | 21,4- | 1 |
| 77 | 25+/- | 1 |
| 78 | 26.3± | 1 |
| 79 | 3.3-2.8 | 1 |
| 80 | 30.1± | 1 |
| 81 | 32,092 | 1 |
| 82 | 37,348 | 1 |
| 83 | 38.6.t | 1 |
| 84 | 4-diazobut-2-enenitriles | 1 |
| 85 | 4.0±4.0 | 1 |
| 86 | 41.4/16.3 | 1 |
| 87 | 47+/- | 1 |
| 88 | 5.1±4.0 | 1 |
| 89 | 531+/- | 1 |
| 90 | 6.0±4.6 | 1 |
| 91 | 60+/- | 1 |
| 92 | 66·61± | 1 |
| 93 | 7.5±4.0 | 1 |
| 94 | 7.9/10.5 | 1 |
| 95 | 75mg-300mg | 1 |
| 96 | 8.4/9.1 | 1 |
| 97 | 8.5± | 1 |
| 98 | 8.6/10.5 | 1 |
| 99 | 8.8/10.3 | 1 |
| 100 | 80.6± | 1 |
| 101 | abuse.only | 1 |
| 102 | accuitomo | 1 |
| 103 | acetaminophen/tramadol | 1 |
| 104 | adv-cat | 1 |
| 105 | aml/om+hctz | 1 |
| 106 | anemia-almost | 1 |
| 107 | anoter | 1 |
| 108 | aplio™ | 1 |
| 109 | apo-carvedilol | 1 |
| 110 | appetite.approximately | 1 |
| 111 | approcimately | 1 |
| 112 | approximately/= | 1 |
| 113 | baseline-to-week | 1 |
| 114 | basses | 1 |
| 115 | bicuculline- | 1 |
| 116 | c=omeprazole | 1 |
| 117 | ca-free | 1 |
| 118 | conaissance | 1 |
| 119 | cr-exempt | 1 |
| 120 | cyanoalkene | 1 |
| 121 | cyanovinylcarbenes | 1 |
| 122 | d=omeprazole | 1 |
| 123 | doctaxel | 1 |
| 124 | echoview | 1 |
| 125 | eight-layer | 1 |
| 126 | encephale | 1 |
| 127 | epiduralfentanyl | 1 |
| 128 | fibromyalgia.with | 1 |
| 129 | flutrimazol | 1 |
| 130 | fraxiparine | 1 |
| 131 | futura/oasis | 1 |
| 132 | glantz | 1 |
| 133 | heldfor | 1 |
| 134 | honey-processed | 1 |
| 135 | hsp27/actin | 1 |
| 136 | i271 | 1 |
| 137 | icp-aes/icp-ms. | 1 |
| 138 | ifn-beta-la | 1 |
| 139 | iief- | 1 |
| 140 | imiqimod | 1 |
| 141 | increased- | 1 |
| 142 | intramuscolarly | 1 |
| 143 | intraperitoenal | 1 |
| 144 | isoglucidic | 1 |
| 145 | katg3 | 1 |
| 146 | ketocholesterol | 1 |
| 147 | lamivudine/zidovudine/nevirapine | 1 |
| 148 | lansoprasole | 1 |
| 149 | lyc-o-lutein | 1 |
| 150 | mathayom | 1 |
| 151 | mep-monitored | 1 |
| 152 | mg/m²+doxorubicin | 1 |
| 153 | microg/salmeterol | 1 |
| 154 | nagina | 1 |
| 155 | ni-11.3 | 1 |
| 156 | non-chylomicrons | 1 |
| 157 | nrbf2-beclin | 1 |
| 158 | p.val | 1 |
| 159 | padma® | 1 |
| 160 | patients-approximately | 1 |
| 161 | performe | 1 |
| 162 | phosphodiesterase-type | 1 |
| 163 | pneumovax® | 1 |
| 164 | poor.in | 1 |
| 165 | pre-adding | 1 |
| 166 | precaspase | 1 |
| 167 | prefitted | 1 |
| 168 | psychiatry-module | 1 |
| 169 | pulse-duration | 1 |
| 170 | pulse-repetition-rate | 1 |
| 171 | pyrx | 1 |
| 172 | quickwhite | 1 |
| 173 | rate.in | 1 |
| 174 | re-arranging | 1 |
| 175 | re-collected | 1 |
| 176 | reaction-free | 1 |
| 177 | rhze | 1 |
| 178 | rispi-sonic/micromega | 1 |
| 179 | sek-approximately | 1 |
| 180 | soylife | 1 |
| 181 | studies.trazodone | 1 |
| 182 | sybyl-x | 1 |
| 183 | t3:1 | 1 |
| 184 | tafa | 1 |
| 185 | technokroma | 1 |
| 186 | tfg-gbe-tfe-ast | 1 |
| 187 | triazacycloheptatetraenes | 1 |
| 188 | ttou | 1 |
| 189 | uno6 | 1 |
| 190 | usd10 | 1 |
| 191 | xviii-first | 1 |
| 192 | μg/gestodene | 1 |
| 193 | •only | 1 |
| 194 | •some | 1 |
| 1 | 'affects | 3 |
| 2 | 'mikurasima | 1 |
| 3 | 'revman | 1 |
| 4 | -1093+59 | 1 |
| 5 | -across | 1 |
| 6 | /design | 1 |
| 7 | 0.1+/- | 1 |
| 8 | 0.34-10.8 | 1 |
| 9 | 0.5nmol/kbw | 1 |
| 10 | 0·93-3·87 | 1 |
| 11 | 11-to | 1 |
| 12 | 11.6± | 1 |
| 13 | 13.2± | 1 |
| 14 | 135·07± | 1 |
| 15 | 162/217 | 1 |
| 16 | 17.7± | 1 |
| 17 | 1986-april | 1 |
| 18 | 1h-session | 1 |
| 19 | 2,3,4,5-tetrahydro-1h-carbazole-6,11-diones | 1 |
| 20 | 2,39 | 1 |
| 21 | 2-aryl-2,3-dihydrobenzofuran | 1 |
| 22 | 2-pyrimidinylnitrenes | 2 |
| 23 | 20.888 | 1 |
| 24 | 2001-november | 1 |
| 25 | 2003-november | 1 |
| 26 | 2005-september | 1 |
| 27 | 2006-august | 1 |
| 28 | 21,4- | 1 |
| 29 | 25+/- | 1 |
| 30 | 26.3± | 1 |
| 31 | 3-keto-1,5-bisphosphonates | 3 |
| 32 | 3.3-2.8 | 1 |
| 33 | 30.1± | 1 |
| 34 | 32,092 | 1 |
| 35 | 37,348 | 1 |
| 36 | 38.6.t | 1 |
| 37 | 4-amino-3-methyl-5-styrylisoxazole | 2 |
| 38 | 4-diazobut-2-enenitriles | 1 |
| 39 | 4.0±4.0 | 1 |
| 40 | 41.4/16.3 | 1 |
| 41 | 47+/- | 1 |
| 42 | 5.1±4.0 | 1 |
| 43 | 531+/- | 1 |
| 44 | 6.0±4.6 | 1 |
| 45 | 60+/- | 1 |
| 46 | 66·61± | 1 |
| 47 | 7.5±4.0 | 1 |
| 48 | 7.9/10.5 | 1 |
| 49 | 75mg-300mg | 1 |
| 50 | 8.4/9.1 | 1 |
| 51 | 8.5± | 1 |
| 52 | 8.6/10.5 | 1 |
| 53 | 8.8/10.3 | 1 |
| 54 | 80.6± | 1 |
| 55 | abuse.only | 1 |
| 56 | accuitomo | 1 |
| 57 | acetaminophen/tramadol | 1 |
| 58 | adi-peg | 3 |
| 59 | adv-cat | 1 |
| 60 | aml/om+hctz | 1 |
| 61 | anemia-almost | 1 |
| 62 | anoter | 1 |
| 63 | antho | 8 |
| 64 | anthropac | 2 |
| 65 | anti-polio | 4 |
| 66 | aplio™ | 1 |
| 67 | apo-carvedilol | 1 |
| 68 | appetite.approximately | 1 |
| 69 | approcimately | 1 |
| 70 | approximately | 12,394 |
| 71 | approximately/= | 1 |
| 72 | approximatively | 7 |
| 73 | approximatly | 3 |
| 74 | as101 | 3 |
| 75 | atleast | 3 |
| 76 | baseline-to-week | 1 |
| 77 | basses | 1 |
| 78 | biasp | 82 |
| 79 | bicuculline- | 1 |
| 80 | c=omeprazole | 1 |
| 81 | ca-free | 1 |
| 82 | cand | 2 |
| 83 | circa | 15 |
| 84 | clnp | 23 |
| 85 | conaissance | 1 |
| 86 | corpitolinol | 5 |
| 87 | coumarin-tween | 3 |
| 88 | cr-exempt | 1 |
| 89 | crambescidin | 2 |
| 90 | cyanoalkene | 1 |
| 91 | cyanovinylcarbenes | 1 |
| 92 | d=omeprazole | 1 |
| 93 | doctaxel | 1 |
| 94 | echoview | 1 |
| 95 | eight-layer | 1 |
| 96 | enalapril/nitrendipine | 5 |
| 97 | encephale | 1 |
| 98 | epiduralfentanyl | 1 |
| 99 | epub | 7 |
| 100 | fagaridine | 2 |
| 101 | fibromyalgia.with | 1 |
| 102 | flutrimazol | 1 |
| 103 | fraxiparine | 1 |
| 104 | futura/oasis | 1 |
| 105 | gi-containing | 6 |
| 106 | glantz | 1 |
| 107 | guna-interleukin | 3 |
| 108 | heldfor | 1 |
| 109 | honey-processed | 1 |
| 110 | hsp27/actin | 1 |
| 111 | i271 | 1 |
| 112 | icp-aes/icp-ms. | 1 |
| 113 | ifn-beta-la | 1 |
| 114 | iief- | 1 |
| 115 | imiqimod | 1 |
| 116 | increased- | 1 |
| 117 | intramuscolarly | 1 |
| 118 | intraperitoenal | 1 |
| 119 | isoglucidic | 1 |
| 120 | ispm | 4 |
| 121 | itca | 19 |
| 122 | katg3 | 1 |
| 123 | ketocholesterol | 1 |
| 124 | l-nitromonomethylarginine | 2 |
| 125 | lamivudine/zidovudine/nevirapine | 1 |
| 126 | lansoprasole | 1 |
| 127 | lexis | 3 |
| 128 | lyc-o-lutein | 1 |
| 129 | mathayom | 1 |
| 130 | mep-monitored | 1 |
| 131 | mg/dimenhydrinate | 4 |
| 132 | mg/m²+doxorubicin | 1 |
| 133 | microg/salmeterol | 1 |
| 134 | microgynon | 8 |
| 135 | microgynon® | 5 |
| 136 | monosomies | 2 |
| 137 | nagina | 1 |
| 138 | ni-11.3 | 1 |
| 139 | non-chylomicrons | 1 |
| 140 | novomix | 2 |
| 141 | nrbf2-beclin | 1 |
| 142 | osteoform | 3 |
| 143 | p.val | 1 |
| 144 | padma | 53 |
| 145 | padma® | 1 |
| 146 | patients-approximately | 1 |
| 147 | pegasus-timi | 3 |
| 148 | performe | 1 |
| 149 | phosphodiesterase-type | 1 |
| 150 | plaza | 2 |
| 151 | pneumovax® | 1 |
| 152 | poloxalene | 3 |
| 153 | polysorbate | 29 |
| 154 | poor.in | 1 |
| 155 | pre-adding | 1 |
| 156 | precaspase | 1 |
| 157 | prefitted | 1 |
| 158 | psychiatry-module | 1 |
| 159 | pulse-duration | 1 |
| 160 | pulse-repetition-rate | 1 |
| 161 | pyrx | 1 |
| 162 | quickwhite | 1 |
| 163 | rate.in | 1 |
| 164 | re-arranging | 1 |
| 165 | re-collected | 1 |
| 166 | reaction-free | 1 |
| 167 | registred | 2 |
| 168 | regprecise | 6 |
| 169 | rhze | 1 |
| 170 | rispi-sonic/micromega | 1 |
| 171 | roughly | 398 |
| 172 | roux-en- | 2 |
| 173 | sek-approximately | 1 |
| 174 | soylife | 1 |
| 175 | studies.trazodone | 1 |
| 176 | superdex | 15 |
| 177 | sybyl-x | 1 |
| 178 | t3:1 | 1 |
| 179 | tafa | 1 |
| 180 | technokroma | 1 |
| 181 | tepc | 2 |
| 182 | tfg-gbe-tfe-ast | 1 |
| 183 | triazacycloheptatetraenes | 1 |
| 184 | trombopol | 3 |
| 185 | ttou | 1 |
| 186 | tween | 75 |
| 187 | uno6 | 1 |
| 188 | usd10 | 1 |
| 189 | va/scd | 2 |
| 190 | veramex | 4 |
| 191 | xviii-first | 1 |
| 192 | μg/gestodene | 1 |
| 193 | •only | 1 |
| 194 | •some | 1 |
| 1 | 60+/- | 1 |
| 2 | 0.1+/- | 1 |
| 3 | 531+/- | 1 |
| 4 | 25+/- | 1 |
| 5 | 47+/- | 1 |
| 6 | 21,4- | 1 |
| 7 | increased- | 1 |
| 8 | bicuculline- | 1 |
| 9 | iief- | 1 |
| 10 | roux-en- | 2 |
| 11 | icp-aes/icp-ms. | 1 |
| 12 | 4.0±4.0 | 1 |
| 13 | 5.1±4.0 | 1 |
| 14 | 7.5±4.0 | 1 |
| 15 | usd10 | 1 |
| 16 | 8.4/9.1 | 1 |
| 17 | as101 | 3 |
| 18 | i271 | 1 |
| 19 | t3:1 | 1 |
| 20 | 32,092 | 1 |
| 21 | 8.8/10.3 | 1 |
| 22 | ni-11.3 | 1 |
| 23 | 41.4/16.3 | 1 |
| 24 | katg3 | 1 |
| 25 | 8.6/10.5 | 1 |
| 26 | 7.9/10.5 | 1 |
| 27 | 6.0±4.6 | 1 |
| 28 | uno6 | 1 |
| 29 | 162/217 | 1 |
| 30 | 0·93-3·87 | 1 |
| 31 | 0.34-10.8 | 1 |
| 32 | 3.3-2.8 | 1 |
| 33 | 37,348 | 1 |
| 34 | 20.888 | 1 |
| 35 | 2,39 | 1 |
| 36 | -1093+59 | 1 |
| 37 | approximately/= | 1 |
| 38 | circa | 15 |
| 39 | itca | 19 |
| 40 | tafa | 1 |
| 41 | rispi-sonic/micromega | 1 |
| 42 | ifn-beta-la | 1 |
| 43 | padma | 53 |
| 44 | 'mikurasima | 1 |
| 45 | technokroma | 1 |
| 46 | nagina | 1 |
| 47 | plaza | 2 |
| 48 | epub | 7 |
| 49 | anthropac | 2 |
| 50 | isoglucidic | 1 |
| 51 | tepc | 2 |
| 52 | va/scd | 2 |
| 53 | mep-monitored | 1 |
| 54 | registred | 2 |
| 55 | honey-processed | 1 |
| 56 | re-collected | 1 |
| 57 | prefitted | 1 |
| 58 | cand | 2 |
| 59 | imiqimod | 1 |
| 60 | conaissance | 1 |
| 61 | ca-free | 1 |
| 62 | reaction-free | 1 |
| 63 | soylife | 1 |
| 64 | encephale | 1 |
| 65 | lansoprasole | 1 |
| 66 | c=omeprazole | 1 |
| 67 | d=omeprazole | 1 |
| 68 | 4-amino-3-methyl-5-styrylisoxazole | 2 |
| 69 | psychiatry-module | 1 |
| 70 | •some | 1 |
| 71 | performe | 1 |
| 72 | μg/gestodene | 1 |
| 73 | cyanoalkene | 1 |
| 74 | poloxalene | 3 |
| 75 | fagaridine | 2 |
| 76 | l-nitromonomethylarginine | 2 |
| 77 | lamivudine/zidovudine/nevirapine | 1 |
| 78 | enalapril/nitrendipine | 5 |
| 79 | fraxiparine | 1 |
| 80 | studies.trazodone | 1 |
| 81 | phosphodiesterase-type | 1 |
| 82 | precaspase | 1 |
| 83 | regprecise | 6 |
| 84 | polysorbate | 29 |
| 85 | mg/dimenhydrinate | 4 |
| 86 | pulse-repetition-rate | 1 |
| 87 | quickwhite | 1 |
| 88 | rhze | 1 |
| 89 | adi-peg | 3 |
| 90 | 75mg-300mg | 1 |
| 91 | pre-adding | 1 |
| 92 | re-arranging | 1 |
| 93 | gi-containing | 6 |
| 94 | fibromyalgia.with | 1 |
| 95 | pegasus-timi | 3 |
| 96 | baseline-to-week | 1 |
| 97 | intraperitoenal | 1 |
| 98 | p.val | 1 |
| 99 | doctaxel | 1 |
| 100 | 1986-april | 1 |
| 101 | acetaminophen/tramadol | 1 |
| 102 | apo-carvedilol | 1 |
| 103 | corpitolinol | 5 |
| 104 | trombopol | 3 |
| 105 | microg/salmeterol | 1 |
| 106 | ketocholesterol | 1 |
| 107 | flutrimazol | 1 |
| 108 | epiduralfentanyl | 1 |
| 109 | mathayom | 1 |
| 110 | ispm | 4 |
| 111 | osteoform | 3 |
| 112 | 'revman | 1 |
| 113 | 2-aryl-2,3-dihydrobenzofuran | 1 |
| 114 | tween | 75 |
| 115 | coumarin-tween | 3 |
| 116 | /design | 1 |
| 117 | rate.in | 1 |
| 118 | poor.in | 1 |
| 119 | mg/m²+doxorubicin | 1 |
| 120 | crambescidin | 2 |
| 121 | lyc-o-lutein | 1 |
| 122 | guna-interleukin | 3 |
| 123 | nrbf2-beclin | 1 |
| 124 | hsp27/actin | 1 |
| 125 | 1h-session | 1 |
| 126 | pulse-duration | 1 |
| 127 | microgynon | 8 |
| 128 | antho | 8 |
| 129 | anti-polio | 4 |
| 130 | accuitomo | 1 |
| 131 | 11-to | 1 |
| 132 | clnp | 23 |
| 133 | biasp | 82 |
| 134 | 2005-september | 1 |
| 135 | 2001-november | 1 |
| 136 | 2003-november | 1 |
| 137 | anoter | 1 |
| 138 | eight-layer | 1 |
| 139 | heldfor | 1 |
| 140 | monosomies | 2 |
| 141 | 4-diazobut-2-enenitriles | 1 |
| 142 | triazacycloheptatetraenes | 1 |
| 143 | cyanovinylcarbenes | 1 |
| 144 | 2-pyrimidinylnitrenes | 2 |
| 145 | 2,3,4,5-tetrahydro-1h-carbazole-6,11-diones | 1 |
| 146 | basses | 1 |
| 147 | 3-keto-1,5-bisphosphonates | 3 |
| 148 | futura/oasis | 1 |
| 149 | lexis | 3 |
| 150 | non-chylomicrons | 1 |
| 151 | -across | 1 |
| 152 | 'affects | 3 |
| 153 | 38.6.t | 1 |
| 154 | adv-cat | 1 |
| 155 | cr-exempt | 1 |
| 156 | tfg-gbe-tfe-ast | 1 |
| 157 | atleast | 3 |
| 158 | anemia-almost | 1 |
| 159 | xviii-first | 1 |
| 160 | 2006-august | 1 |
| 161 | ttou | 1 |
| 162 | 0.5nmol/kbw | 1 |
| 163 | echoview | 1 |
| 164 | sybyl-x | 1 |
| 165 | superdex | 15 |
| 166 | veramex | 4 |
| 167 | novomix | 2 |
| 168 | pyrx | 1 |
| 169 | approcimately | 1 |
| 170 | approximately | 12,394 |
| 171 | sek-approximately | 1 |
| 172 | patients-approximately | 1 |
| 173 | appetite.approximately | 1 |
| 174 | approximatively | 7 |
| 175 | roughly | 398 |
| 176 | abuse.only | 1 |
| 177 | •only | 1 |
| 178 | intramuscolarly | 1 |
| 179 | approximatly | 3 |
| 180 | aml/om+hctz | 1 |
| 181 | glantz | 1 |
| 182 | aplio™ | 1 |
| 183 | padma® | 1 |
| 184 | microgynon® | 5 |
| 185 | pneumovax® | 1 |
| 186 | 30.1± | 1 |
| 187 | 66·61± | 1 |
| 188 | 13.2± | 1 |
| 189 | 26.3± | 1 |
| 190 | 8.5± | 1 |
| 191 | 80.6± | 1 |
| 192 | 11.6± | 1 |
| 193 | 17.7± | 1 |
| 194 | 135·07± | 1 |